Pre-market: AIDX.TO Healwell AI C$0.82 on 09 Apr 2026: earnings catalyst ahead

The AIDX.TO stock is trading pre-market at C$0.82 on 09 Apr 2026, with an upcoming earnings date on 13 May 2026 that could move the share price. Healwell AI Inc. (AIDX.TO) shows a 50.57 RSI, year high C$1.66, and market cap C$240,524,464.00. Investors in AI healthcare should watch volume of 195,652.00 shares and average volume of 516,106.00 for signs of conviction.

Pre-market snapshot for AIDX.TO stock

AIDX.TO stock opened pre-market at C$0.85 and is quoting C$0.82 with a day low of C$0.81 and a day high of C$0.88. Volume stands at 195,652.00 versus an average volume of 516,106.00, signaling lighter trading ahead of the earnings window.

The stock trades on the TSX in Canada and has 293,322,517.00 shares outstanding. Market participants should note the 50-day average price of C$0.79 and the 200-day average price of C$1.12 as short- and mid-term reference points.

Business overview and catalysts for AIDX.TO stock

Healwell AI Inc. (AIDX.TO) builds AI decision support tools for preventative care and has a strategic alliance with WELL Health Technologies. This partnership is a core near-term growth catalyst for product trials and commercial rollout.

Earnings on 13 May 2026 and any contract announcements are the primary short-term triggers. Watch company updates and the Reuters coverage for confirmatory news source.

Valuation and financial metrics for AIDX.TO stock

AIDX.TO reports EPS of -0.14 and a trailing PE of -5.86, reflecting current losses. Key ratios include price-to-sales 2.05, price-to-book 1.92, and current ratio 0.91, indicating tight near-term liquidity.

Meyka AI rates AIDX.TO with a score out of 100: 58.04 (C+, HOLD). This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and are not financial advice.

Technical picture and trading cues for AIDX.TO stock

Technicals show RSI 50.57, ADX 21.08, and Bollinger middle band C$0.84, suggesting a neutral trend with room for volatility. The 50-day average of C$0.79 sits just below the current price, offering short-term support.

Downside support aligns near the year low C$0.58 and intraday bands; resistance lies at the year high C$1.66 and the 200-day average C$1.12. Traders should watch volume spikes above 516,106.00 for conviction moves.

Risks and opportunities in AIDX.TO stock

Risks include negative operating cash flow, EPS losses, and a current ratio under 1.00, which raise liquidity concerns. Debt-to-equity stands near 0.69, and interest coverage is negative, which increases financial risk.

Opportunities include continued adoption of AI in preventative care, expansion via WELL Health channels, and improving margins if R&D converts to scalable SaaS revenue. Sector trends in healthcare AI could magnify outcomes.

Forecasts, price targets and market outlook for AIDX.TO stock

Meyka AI’s forecast model projects a monthly price of C$0.65, quarterly C$0.72, and yearly C$0.40. Compared with the current price of C$0.82, the model implies near-term downside of -20.73% (monthly), -12.20% (quarterly), and -51.31% (yearly). Forecasts are model-based projections and not guarantees.

For planning, we present scenario price targets: conservative C$0.55, base C$0.82, and bull C$1.50. These targets reflect balance-sheet risk, revenue conversion assumptions, and a recovery toward the 2025 year high. See more on the company at the Meyka AI AIDX.TO page source.

Final Thoughts

Key takeaways for AIDX.TO stock: Healwell AI Inc. trades at C$0.82 pre-market on 09 Apr 2026 and faces a critical earnings date on 13 May 2026. Financials show a negative EPS of -0.14 and tight liquidity with a current ratio of 0.91, which increases downside risk. Meyka AI rates the stock 58.04 (C+, HOLD) while its forecast model projects monthly C$0.65 and yearly C$0.40, implying model-based downside of -20.73% to -51.31% versus today’s price. Investors focused on AI healthcare should weigh the partnership with WELL Health and sector momentum against weak cash flow and negative margins. Short-term traders can use the C$0.79 50-day average and C$0.58 year low as tactical support levels. Longer-term investors should watch revenue growth, contract wins, and the next earnings report for evidence the AI platform is scaling. Forecasts are model projections, not guarantees, so monitor news flow and volume for real-time confirmation.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.